Ambucetamide - Misplaced Pages

This is the current revision of this page, as edited by JWBE (talk | contribs) at 19:59, 23 September 2024 (removed Category:Phenol ethers; added Category:4-Methoxyphenyl compounds using HotCat). The present address (URL) is a permanent link to this version.

Revision as of 19:59, 23 September 2024 by JWBE (talk | contribs) (removed Category:Phenol ethers; added Category:4-Methoxyphenyl compounds using HotCat)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound Pharmaceutical compound

Ambucetamide
Clinical data

ATC code	none
Identifiers
IUPAC name 2-(dibutylamino)-2-(4-methoxyphenyl)acetamide
CAS Number	519-88-0
PubChem CID	10616
ChemSpider	10171
UNII	131B408RZI
ChEMBL	ChEMBL2104638
CompTox Dashboard (EPA)	DTXSID4057760
ECHA InfoCard	100.007.527
Chemical and physical data
Formula	C₁₇H₂₈N₂O₂
Molar mass	292.423 g·mol
3D model (JSmol)	Interactive image
SMILES O=C(N)C(c1ccc(OC)cc1)N(CCCC)CCCC
InChI InChI=1S/C17H28N2O2/c1-4-6-12-19(13-7-5-2)16(17(18)20)14-8-10-15(21-3)11-9-14/h8-11,16H,4-7,12-13H2,1-3H3,(H2,18,20) Key:WUSAVCGXMSWMQM-UHFFFAOYSA-N
(what is this?) (verify)

Ambucetamide is an antispasmodic found to be particularly effective for the relief of menstrual pain. It was discovered in 1953 by Paul Janssen.

References

Hoekstra JB, Fisher DS, Cull KM, Tisch DE, Dickison HL (September 1957). "Studies with a uterine antispasmodic, ambucetamide". Journal of the American Pharmaceutical Association. 46 (9): 564–568. doi:10.1002/jps.3030460915. PMID 13491452.
Pickles VR, Clitheroe HJ (March 1960). "The effects of ambucetamide on human myometrial and other preparations, and its antagonism to the menstrual stimulant". British Journal of Pharmacology and Chemotherapy. 15 (1): 128–30. doi:10.1111/j.1476-5381.1960.tb01220.x. PMC 1481989. PMID 14432761.

This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it.